January 3, 2023
First startup blooms from Mayo Clinic cell and gene therapy accelerator with $750M Cellectis partnership Seeds from Mayo Clinic’s cell and gene therapy accelerator Mayflower Bioventures […]
December 21, 2022
Mayflower Bioventures Launches its First Spin-Out, Primera Therapeutics, in Strategic Collaboration with Cellectis to Develop a Gene Editing Platform to Treat Mitochondrial Diseases December 29, 2022 […]